Fetal and Childhood Effects of Children Exposed to Opioids, Opioid Maintenance Therapy (OMT), and Methamphetamine In Utero
Authors
Peters, SethDocument Type
Poster AbstractPublication Date
2017-05-16Keywords
opioidsopioid maintenance therapy
fetal and childhood health outcomes
maternal exposure
Maternal and Child Health
Substance Abuse and Addiction
Translational Medical Research
Metadata
Show full item recordAbstract
The opioid use epidemic in the U.S. is a well-known growing problem. According to the U.S. Department of Health & Human Services, opioid use has increased nationally nearly 400% over the past 18 years1. Subsequently, Opioid Maintenance Therapy (OMT), methadone or buprenorphine, is expanding2. Additionally, methamphetamine (MA) use and abuse is a continuing problem worldwide. Rates of MA use are high In the U.S. and overseas rates are greater3. Opioid and MA use affects not only the user, but also friends, family, and the communities close to them4,5. A child exposed to opioids, OMT, and MA in utero may have predispositions to numerous health conditions, which is also a significant impact. After an extensive PubMed search, research appears limited on illnesses, health conditions, and ongoing health related to fetal exposure to these substances. There is a lack of sufficient study on the effects of opioid, OMT, and MA use by expectant mothers on fetal and childhood health outcomes. An exhaustive database search and a retrospective epidemiological study may provide a better understanding of the health risk of children exposed to opioids, OMT, and MA in utero.DOI
10.13028/jza3-nz18Permanent Link to this Item
http://hdl.handle.net/20.500.14038/28217Rights
Copyright the Author(s)Distribution License
http://creativecommons.org/licenses/by-nc-sa/3.0/ae974a485f413a2113503eed53cd6c53
10.13028/jza3-nz18